Assessing Cardiovascular Risk in Geriatric Patients Without Atherosclerotic Cardiovascular Disease

Witold Żurański1, Justyna Nowak2, Aleksander Danikiewicz3

  • 1Third Department of Cardiology, Silesian Center for Heart Disease, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland.

PubMed

Insights

Most elderly individuals over 70 face high atherosclerotic cardiovascular disease (ASCVD) risk, often exceeding thresholds. Age and hypertension are key factors, alongside common issues like malnutrition and polypharmacy.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Age is a primary risk factor for atherosclerotic cardiovascular disease (ASCVD).
  • Nearly all individuals aged 70 and older exceed conventional 10-year ASCVD risk thresholds.
  • ASCVD risk modifiers like malnutrition, polypharmacy, and comorbidities are crucial considerations in older adults.

Purpose of the Study:

  • To estimate the 10-year ASCVD risk in apparently healthy elderly individuals (aged 70+).
  • To characterize this population using biochemical and clinical indicators.
  • To evaluate the prevalence of ASCVD risk modifiers in this demographic.

Main Methods:

  • The study enrolled 253 apparently healthy elderly individuals (70+ years) without established ASCVD.
  • The Systemic Coronary Risk Estimation 2-Older Persons (SCORE2-OP) model was used to assess 10-year ASCVD risk.
  • Biochemical and clinical indicators were evaluated to characterize the participants.

Main Results:

  • 16.2% were high risk, and 83.8% were very high risk for ASCVD; no participants had low risk.
  • The median 10-year ASCVD risk was 23%, with risk significantly increasing with age (75+ years).
  • Age (≥75 years) was strongly associated with very high ASCVD risk (C-statistic 0.92, PPV 99%, NPV 52%).

Conclusions:

  • Elderly individuals without established ASCVD are a heterogeneous group, with most at very high risk.
  • Age and hypertension are the predominant contributors to ASCVD risk in this population.
  • Malnutrition, polypharmacy, and multimorbidity are frequently observed ASCVD risk modifiers.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
278
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
175
Assessment of the Cardiovascular System IV: Auscultation01:25

Assessment of the Cardiovascular System IV: Auscultation

Cardiac auscultation is a clinical skill used to assess heart function and detect abnormalities. It involves listening to heart sounds at specific anatomical locations through a stethoscope.
Normal Heart Sounds
S1 (First Heart Sound)-
S1 is made by the closure of the mitral and tricuspid valves (atrioventricular valves), marking the beginning of systole.
S2 (Second Heart Sound)-
S2 is made by the closure of the aortic and pulmonic valves (semilunar valves), marking the end of the systole.
210
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
1
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
520
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57